WHO approved adding two Bundibugyo Ebola vaccine candidates to a clinical trial led by the Democratic Republic of the Congo’s National Institute for Biomedical Research with international partners, including WHO. Oxford and the Serum Institute of India are developing one candidate, and Moderna the other. The outbreak has killed more than 5,300 people; no vaccine is approved for the strain.
3 reports from 3 publishers confirmed as covering this specific event.
Reporting from 3 identified publishers across this event arc.
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 911 of 22444
Same format. Every time.
Continue reading — sign in or create a free account with